Digital Clinical Trials: Bridging the Data Silos Among Sponsors, Hospitals, Physicians, and Patients
“Despite standardized procedures, challenges such as slow clinical trial progress and difficulties in patient enrollment persist, which ultimately stem from the lack of efficient communication among stakeholders.”It is common to hear principal investigators at clinical trial sites express such sentiments. Sponsors are also troubled by the same issues:How to Achieve Effective Data Interoperability Between Systems and Eliminate the Various Challenges Posed by Data Integration?
Digitalization requirements now cover nearly all aspects of clinical trials. As the core system for clinical research data capture, Electronic Data Capture (EDC) interfaces with multiple systems, including Clinical Trial Management Systems (CTMS), electronic Trial Master Files (eTMF), and Pharmacovigilance (PV) platforms. Furthermore, these various systems are interconnected rather than operating in isolation. However, the lack of effective information exchange among these systems has resulted in data silos, leading to significant redundant work and severely impairing data utilization efficiency.
How can we break down the data silos among sponsors, hospitals, physicians, and patients to truly achieve efficient collaboration among all parties in clinical research?
To address these questions, on Friday, December 2, 2022, from 20:00 to 21:30,VCBeat SelectJoin HandsECOV Tech, co-hosting an online live public lecture. This course will"Digital Clinical Trials: How to Break Down Data Silos Among Sponsors, Hospitals, Physicians, and Patients?"Focusing on the theme, and combining practical case studies, this presentation shares how data interoperability is achieved across all stages of digital clinical trials.
This session also featuresProfessor of Hematology and Oncology, The First Affiliated Hospital of Hainan Medical University、Chief Physician Hao XinbaoandChief Data Officer, Clinical Data Science Center, Jiangsu Hengrui Medicine Co., Ltd.Yan Chongchao, participate together《Data Interoperability: The Inescapable Hurdle in Clinical Trials》Themed Roundtable Discussion: Helping Enterprises Understand Data Inter-the importance of interoperability, and provide insights for enterprises to achieve data interoperability.
Viewers who participated in the live interactive consultation also received complimentary advisory services from iCoF on “How to Conduct Fully Digital Clinical Trials,” along with a 50% discount for the first year of the inaugural project under the 3Q XaaS service series. During the live stream, attendees also had the chance to receive cash red envelopes!Scan the QR code in the poster below to register for the live stream.：
I. Clinical Trial Informatics Ushers in the Second Technological Revolution
II. Challenges Facing the Development of Clinical Trial Informatization in China
III. Industry Discussion: Development Trends of Digital Clinical Trials in China
IV. How to Systematically Address the Problem of Data Silos
V. Understanding the 3Q Digital Intelligence Clinical Acceleration Service Platform
VI. Case Studies
Founder/General Manager of Pharmaceutical Companies or CROs
[Recommendation: ★★★★★]
Head of Clinical Trial Department at Pharmaceutical or CRO Companies
[Recommendation: ★★★★★]
If you belong to the above-mentioned groups or have products that urgently need conversion, be sure not to miss this content-rich open class.
Yan Chongchao | Chief Data Officer, Clinical Data Science Center, Hengrui Medicine
Formerly served as the Head of Technical Operations in the Data Services Department of Pfizer’s China R&D Center. Previously conducted medical research at the Italian National Institute of Health, the University of Arizona College of Medicine, and the New York University School of Medicine, and has published more than 50 academic papers in domestic and international journals. He is the author of China’s first monograph on data management, *Data Management in Pharmaceutical Clinical Research*.
Lu Min | Founder and CEO of Yikefu Technology
Founder and CEO of E-Clinical Technology; Zhejiang Province Overseas High-Level Talent. Holds a Master’s degree from Zhejiang University, a Master’s degree from West Chester University (USA), and is a PhD candidate. Member of the Drug Information Association (DIA) and the Society for Clinical Data Management (SCDM). With 20 years of dedicated focus on the research, development, application, and promotion of information technology for clinical trials, and over a decade of experience serving sponsors and CROs in Europe and the United States as well as the Chinese market, he possesses extensive industry expertise in the digitalization of clinical trials. During the 12th and 13th Five-Year Plan periods, he successfully completed the planning, construction, and implementation guidance of GCP technical platforms for new drug clinical evaluation for dozens of large Grade IIIA hospitals.
Hao Xinbao | Professor of Hematology and Oncology, Chief Physician, The First Affiliated Hospital of Hainan Medical University
M.D., Professor of Hematology and Oncology, Chief Physician, and Doctoral Supervisor at the First Affiliated Hospital of Hainan Medical University. He graduated from the Fourth Military Medical University and served as a postdoctoral fellow and researcher at Tsinghua University, Pennsylvania State University (USA), and the University of Michigan. With over 30 years of experience in the medical treatment, teaching, and research of hematological diseases and tumors, he has been engaged in the development and clinical evaluation of small-molecule chemical drugs, macromolecular protein therapeutics, and cell therapy agents. He has presided over more than 20 research projects funded by the National Natural Science Foundation of China and provincial/ministerial-level programs, and has published over 100 journal articles both domestically and internationally. He was honored as an Outstanding Scientific and Technological Worker of Hainan Province (2015) and a Leading Scientific and Technological Talent of Hainan Province (2020).
Hangzhou E-Cuff Technology Co., Ltd., originating from the United States and established in China, has dedicated 20 years of relentless effort to providing professional integrated information technology solutions for clinical trials, software services, and one-stop clinical research acceleration services for clinical research centers, sponsors, CROs, and regulatory authorities. The company pioneered the full-process digitalization of clinical trials in China, cumulatively serving over 60% of registered clinical projects conducted in the country. It has provided integrated clinical research platform solutions to more than 100 Grade III Class A hospitals and participated in the construction of clinical evaluation technology platforms for major new drug creation under the National Ministry of Science and Technology’s “12th Five-Year” and “13th Five-Year” Plans at multiple hospitals. The company has earned high recognition from leading domestic Grade III Class A hospitals such as West China Hospital of Sichuan University, Fudan University Shanghai Cancer Center, and Sun Yat-sen University Cancer Center, as well as international pharmaceutical companies including IQVIA, Pfizer, and AstraZeneca.
“Artery Open Course” is one of the branded columns under VCBeat’s “VCBeat Select.” Centered on addressing development pain points and exploring systemic solutions in the healthcare sector, it leverages an online live-streaming platform for knowledge sharing and exchange. By continually inviting seasoned industry practitioners and experts to collaboratively develop a series of thematic courses, it aims to provide healthcare enterprises with in-depth, high-value practical insights. Artery Open Course: Making the selection of knowledge simpler.
Scan the QR code below to contact the assistant and schedule a live broadcast.
(If already added, please proactively contact the assistant)
